|Type||antihistamine, allergy Medication|
|Manufacturer||Johnson & Johnson|
In the United States and Canada, it is the first-generation antihistamine diphenhydramine. Diphenhydramine can also cause sleepiness. The product is not recommended for use in children under 6 where it has caused fatalities.
Some products marketed in Australia and New Zealand as a cough medicine with the Benadryl name contain diphenhydramine. In the United Kingdom, the active component of Benadryl is often the antihistamine acrivastine or cetirizine.
Benadryl is available for by mouth or topical use. It is marketed without a prescription by Johnson & Johnson subsidiary McNeil Consumer Healthcare. Before 2007, Benadryl was marketed by Pfizer Consumer Healthcare (originally Warner–Lambert).
- "Benadryl oral : Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD". WebMD. Retrieved 2017-02-04.
- A mother’s warning after babysitter allegedly gives infant a lethal dose of Benadryl By Lindsey Bever, Washington Post, June 7, 2016
- Nine JS, Rund CR. (March 2006). "Fatality from diphenhydramine monointoxication: a case report and review of the infant, pediatric, and adult literature". Am J Forensic Med Pathol. 27 (1): 36–41. doi:10.1097/01.paf.0000188093.45675.ee. PMID 16501346.
- "ARTG, PI and CMI results searching for Benadryl". Department of Health Therapeutic Goods Administration, Australia.
- "Benadryl Allergy Relief - Summary of Product Characteristics". eMC. 21 May 2016. Retrieved 11 December 2016.
- "Benadryl Allergy One A Day 10mg Tablets - Summary of Product Characteristics". eMC. 11 November 2015. Retrieved 11 December 2016.
- "Johnson & Johnson to Acquire Pfizer Consumer Healthcare" (Press release). Johnson & Johnson. June 26, 2006. Retrieved November 19, 2009.
- "Johnson & Johnson Completes Acquisition Of Pfizer Consumer Healthcare" (Press release). Johnson & Johnson. December 20, 2006. Retrieved November 19, 2009.